AmacaThera Secures Funding to Initiate Phase I Trial of Non-Opioid Pain Control Therapeutic
AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has raised $3.25 million CAD in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners.